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Purpose: To improve the SNR of hyperpolarized carbon-13 MRI of [1-13C]pyruvate
using a multispectral variable flip angle (msVFA) scheme in which the spectral profile and flip angle vary dynamically with time.
Methods: Each image acquisition in a time-resolved imaging experiment used a
unique spectrally varying RF pulse shape for msVFA. Therefore, the flip angle for
every acquisition was optimized for pyruvate and each of its metabolites to yield the
highest SNR across the acquisition. Multispectral VFA was compared with a spectrally varying constant flip-angle excitation model through simulations and in vivo. A
modified broadband chemical shift-encoded gradient-echo sequence was used for in
vivo experiments on six pregnant guinea pigs. Regions of interest placed in the placentae, maternal liver, and maternal kidneys were used as areas for SNR measurement.
Results: In vivo experiments showed significant increases in SNR for msVFA relative to constant flip angle of up to 250% for multiple metabolites.
Conclusion: Hyperpolarized carbon-13 imaging with msVFA excitation produces
improved SNR for all metabolites in organs of interest.
KEYWORDS
carbon-13, hyperpolarized MRI, metabolism, pyruvate, RF pulse design
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IN TRO D U C T ION

The placenta produces a variety of biomolecules during pregnancy that are important for both maternal and fetal metabolism.1 In vivo assessment of placental metabolism would
allow us to characterize healthy metabolism at all stages
of pregnancy and investigate potential placental metabolic
abnormalities in conditions such as intra-uterine growth

restriction.2 Imaging assessment of the placenta during pregnancy is generally limited to the nonionizing imaging modalities of ultrasound and MRI. These imaging techniques can
contribute structural information and limited functional data
about the placenta.2,3
Hyperpolarized carbon-13 MRI (HP13C-MRI) is an ideal
imaging modality for real-time in vivo monitoring of metabolism. Using dissolution dynamic nuclear polarization
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methods, it is possible to temporarily increase the signal
up to 10 000 fold and acquire images of the distribution of
molecules enriched with the hyperpolarized substrate.4 This
technique has a variety of applications in research, including
tumor monitoring, inflammation, cardiac disease, and fetoplacental development.5,6
One of the more common HP13C-MRI substrates is
13
[1- C]pyruvate, which, following an intravenous injection,
allows us to resolve signal from its metabolites: lactate, alanine, and bicarbonate. Pyruvate metabolism is a key step in
glycolysis and is indicative of normal and abnormal cell function. The metabolic by-products of pyruvate follow different
metabolic pathways, some aerobic and some anaerobic, and
the metabolic fates of these biomolecules provide insight to
the biological state of the region or organ of interest. The
metabolic conversion rate constant from pyruvate to a metabolite (for example, KPL is the conversion rate of pyruvate
→ lactate) can be calculated from the time-resolved measurements of the different metabolites and provides a quantitative
measure of metabolism related to enzyme concentrations in
vivo.7 Measuring the entire concentration time curve of each
metabolite is necessary for a robust sampling of data in order
to calculate metabolic rates; as such, a sufficiently high SNR
must be maintained throughout the entire acquisition.
The metabolites of pyruvate we wish to image exist at
distinct chemical shifts (between −9.7 and 12.6 ppm relative
to pyruvate). Because the metabolism of the injected pyruvate occurs rapidly, the relative abundance of each metabolite
changes over the course of the experiment. The metabolites
are typically found in quantities over 6-fold lower than pyruvate. In past experiments we took advantage of this by using
a spectrally varying RF pulse, such that pyruvate is exposed
to a smaller flip angle than its metabolites that are lower in
abundance.5 This flip-angle scheme is spectrally varying but
constant in time and will be referred to as the constant flip
angle (CFA) scheme.
The rapid T1 decay of the hyperpolarized state provides
challenges to maximizing SNR. Previous HP13C-MRI studies8-14 have addressed this by proposing variable flip angle
(VFA) schemes that increase the flip angle over time for one
metabolite. These studies typically use a spectral spatial RF
pulse shape and vary the pulse amplitude at each excitation,
continuously increasing to 90° to maintain a constant signal
from a single spectral peak of a hyperpolarized 13C molecule
despite the rapid decay of polarization.
We aim to expand on the CFA scheme to optimize SNR in
HP13C-MRI experiments by introducing an approach that allows us to deliver optimized time-varying flip angles to each
metabolite by taking advantage of the spectral variance of CFA.
This will be referred to as the multispectral variable flip angle
(msVFA) scheme. The individual trajectories for each metabolite using msVFA are calculated using previously published
VFA methods and are applied to each metabolite simultaneously

|

1511

by progressively varying both the shape and amplitude of the
spectrally varying pulse. This allows us to produce a distinct
VFA trajectory for each metabolite and apply the SNR benefits
associated with VFA to all metabolites simultaneously.15
In this study we compare the msVFA to the CFA scheme.
We have chosen to compare CFA to msVFA, as it allows us
to compare the SNR for all four metabolites of interest simultaneously. Additionally, this comparison allows us to introduce an alternative to the spectral spatial RF method as
an improvement of the current IDEAL technique. Therefore,
we are interested in investigating the addition of time-varying
flip angles to the CFA method to provide optimal SNR for
multiple metabolites simultaneously.
We hypothesize that the msVFA scheme will provide
SNR equivalent to VFA for each metabolite; therefore, it will
significantly increase SNR throughout the experiment for
each metabolite compared with the CFA scheme. We believe
that msVFA has the potential to improve HP13C-MRI image
quality in a variety of research applications, including (but
not limited to) fetoplacental research.

2
2.1

|

M ETHODS

|

Simulations

Flip angles for each metabolite were calculated using the
method described by Xing et al,13 which takes into account
both the T1 decay and metabolic conversion of each metabolite. This method was used to calculate the flip angles that
would optimize SNR for each metabolite throughout the experiment. The calculated flip angles for the msVFA scheme
were compared with a CFA scheme previously described by
Friesen-Waldner et al5 Figure 1 shows the flip-angle trajectories applied in this work for both of these methods.
Bloch equations were used to simulate the SNR of different metabolites using MATLAB 2018a (MathWorks,
Natick, MA). Equation 1 was used to estimate the SNR at
each nth time point for every metabolite (met), in which the
concentration of each metabolite was calculated using the
estimated T1 decay and metabolic conversion rates found in
the literature.16,17 The predicted SNR resulting from using
the implemented flip angle in msVFA was compared with
the predicted SNR using the exact VFA for each metabolite.
− (n−1)TR
T

SNRmet (n) = [met (n)] e

1met

(sin 𝜃) cos 𝜃 n

(1)

2.2 | Multispectral VFA implementation and
verification
In the msVFA experiments, we apply a unique RF waveform for each image acquisition.15 Additional improvement
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would likely be possible by applying a unique RF waveform
for each excitation of each image. This may be feasible for
single-shot pulse-and-acquire-type sequences but becomes
impractical to implement for the thousands of custom RF
pulse shapes required for the sequence used here.
The double Gaussian pulse allows us to implement unique
flip angles for each metabolite; however, the double Gaussian

FIGURE 1

The desired flip-angle trajectories for each
metabolite are shown for constant flip angle (CFA; top) and
multispectral variable flip angle (msVFA; bottom) strategies. These
flip angles were achieved using a double Gaussian RF pulse. Dotted
vertical lines indicate the start time of each acquisition

SMITH et al.

pulse shape limits our accuracy in delivering the exact calculated flip angles to every metabolite. If we were only interested in observing two or three metabolites, the double
Gaussian pulse could be used to deliver the exact calculated
flip angles; however, with four metabolites we have to make
some approximations due to the different spectral positions.
This is why lactate and alanine are delivered the same flip
angle in msVFA experiments.
For our 13C acquisitions, we used a quadrature volume
transmit and receive coil (12 cm diameter, 19 cm long).18
The desired flip angles were applied to each metabolite using
double Gaussian RF spectral profiles designed for each acquisition. The RF profiles for each acquisition are shown in
Figure 2.
These RF pulses were implemented in a version
of our previously described chemical shift–encoded
[1-13C]pyruvate imaging pulse sequence.5,15,18 The modified pulse sequence was tested on a phantom containing
7 mol/L thermal [1-13C]sodium acetate doped with a gadolinium-based contrast agent19 to ensure that RF pulses
were scaling appropriately to prescribed flip angles over
time. Frequency sweeps of the RF pulses were used to determine the RF amplitude at various chemical shifts relevant to [1-13C]pyruvate imaging. The pulse sequence was
run at a longer TR (1.5 seconds) compared with hyperpolarized experiments to permit for the T1 recovery of the
thermal phantom.

2.3

|

Animal experiments

Six pregnant adult guinea pigs (gestational age = 48.2 ± 11.7
days, number of pups = 3.4 ± 0.9) were imaged under the
approval of the institution’s Animal Care Committee. Due to

F I G U R E 2 Double Gaussian RF
spectral profile used in each msVFA
acquisition, centered on the pyruvate peak.
The resonant frequency of each metabolite
is indicated by vertical dashed lines. The
magnitude and shape of the RF profile
progressively changes with each acquisition
to follow the msVFA trajectory
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a technical failure of the RF coil in one experiment, we excluded one animal from analysis, leaving a total of 5 guinea
pigs and 17 placentae. Animals were anesthetized using 4.5%
isoflurane with 2-L/min O2 and maintained between 1.5%
and 2.5% isoflurane with 2-L/min O2. Animal vital signs
(breathing, heart rate, temperature, and blood oxygenation)
were monitored throughout the experiment. Experiments
were done at approximately the same time of day, and all animals were fasted for 2 hours before the experiment to standardize their metabolic state at the start of the experiment. All
animals underwent an ultrasound examination 3 days before
the MRI experiment to confirm pregnancy.
Each animal received two pyruvate injections during
an experiment, one imaged with CFA and the other with
msVFA. The order of the msVFA and CFA acquisitions were
randomized between experiments. The second injection occurred approximately 1 hour after the first, to allow time for
hyperpolarization of the second dose of pyruvate.
For each injection, [1-13C]pyruvic acid (Cambridge
Isotope Laboratories, Tewksbury, MA) containing 15-mM
OX63 trityl radical (Oxford Instruments, Abingdon, United
Kingdom) and 1-mM ProHance (Bracco, Milan, Italy) was
hyperpolarized using the Hypersense DNP polarizer (Oxford
Instruments). A total of 75 mg/kg of the hyperpolarized
250-mM [1-13C]pyruvate solution was delivered as a bolus
injection through intravenous catheter into the saphenous vein
over approximately 12 seconds, approximately 15 seconds
after the dissolution had been released from the polarizer.
Imaging was initiated 7.5 seconds after the start of pyruvate
injection. An image was acquired every 7.5 seconds following the first acquisition, resulting in a total of seven images
acquired at different time points. Hyperpolarized imaging
was done using a 3D multiphase broadband fast gradient
recalled multi-echo pulse sequence with the following
parameters: FOV = 20 × 0.6 cm, slice = 8.5 mm, bandwidth =
8.93 kHz, echoes = 8, number of excitations = 1, echo train
length = 4, first TE = 4.2 ms, echo spacing = 1.1 ms, and
acquisition time = 7.5 seconds.
The T1-weighted gradient echo (TR/ TE = 5.1 ms/2.4 ms,
flip angle = 15°, number of averages = 4, slice thickness =
0.9 mm, total imaging time ~ 7 minutes) and T2-weighted spin
echo (TR/TE = 2000 ms/120 ms, number of averages = 2,
slice thickness = 0.9 mm, total imaging time ~ 7 minutes)
images with 0.875 × 0.875 mm2 in-plane resolutions were
obtained as anatomical references for the 13C images. All
experiments were done on a 3T MRI system (Discovery
MR750; GE Healthcare, Waukesha, WI). The 1H images
were acquired using a 32-element human cardiac coil array
(In Vivo, Gainesville, FL), and 13C images were acquired
using a custom-built 13C birdcage coil (Morris Instruments,
Ottawa, Canada). Polarization levels were measured with a
multiple-quantum coherences spectrometer shortly after the
dispensation of the sample for each injection.

|
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Signal-to-noise ratios

The SNR of the in vivo images was calculated as the mean
signal in a region of interest (ROI) divided by the SD of
signal in a signal-free ROI placed outside the animal. The
ROIs were drawn on the T1 images for each placenta, maternal liver, and maternal kidney, and then transferred to the
HP13C images. The SNR was calculated for each metabolite
and acquisition. Paired t-tests were done to compare the SNR
for each metabolite in each ROI. Significance was defined at
0.05 for this test.

3
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RESULTS

Using the msVFA double Gaussian pulse, we are able to
achieve flip angles very similar to those of the optimal
VFA calculated for each metabolite. Bloch simulations
found that the predicted SNR using the flip angles implemented with msVFA was very similar to the predicted SNR
using the exact VFA calculated for each metabolite. The
SNR ratio summed over time for each metabolite using
msVFA compared with the true VFA are as follows: 97%
for pyruvate, 89% for lactate, 97% for alanine, and 95% for
bicarbonate.
An increase in SNR in the placentae was observed for all
metabolites using msVFA at time points up to 37.5 seconds,
as displayed in Figure 3. We observed statistically significant
(P < 0.00005) increases in SNR for pyruvate, lactate, and
bicarbonate signal in the placentae using the msVFA acquisition compared with the CFA acquisition. An exception of
this SNR increase in the placentae was the alanine signal;
however, placental alanine SNR was very low, suggesting
that very little alanine was being produced in the placentae,
and as such it is not possible to increase the SNR when negligible signal is present.
We noticed significant increases of pyruvate and lactate
SNR in the maternal liver (P = 0.005 and P = 0.006, respectively). We did not find a significant difference in the
SNR of alanine and bicarbonate in the maternal liver, but low
SNR indicates that very little alanine and bicarbonate were
produced in the maternal liver. We observed a significant increase in pyruvate SNR using msVFA in the maternal kidneys (P = 0.015) and noticed trends of increased mean SNR
using msVFA for all metabolites (see Figure 3).
We did not typically see an increase in SNR using msVFA
at the last time point (52.5 seconds), as there was not much
hyperpolarized signal left to acquire at this time point. In
some cases, we saw an increased SNR in the CFA images
at 52.5 seconds, and this may be due to the fact that CFA
is less efficient at using all of the signal by the end of the
scan, leaving “wasted” signal. The SNR was not corrected
for polarization level in this analysis, because all polarization
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F I G U R E 3 Mean SNR for each
metabolite averaged over all placenta (A),
maternal liver (B), and maternal kidney
(C) regions of interest (ROIs). The mean
SNR at each time point may be compared
between msVFA (red squares) and CFA
(blue circles) acquisitions. A, The increased
SNR provided by the msVFA acquisition is
apparent for all metabolites, except alanine.
This is likely due to limited production of
alanine in the placenta providing very little
metabolite signal, which could be increased
by the use of msVFA. B, The increased
SNR provided by the msVFA acquisition is
apparent for pyruvate and lactate, although
there is limited improvement for alanine
and bicarbonate. C, There appears to be
an increased mean SNR using msVFA for
all metabolites in maternal kidney ROIs;
however, these trends were not found to
be significant. Note that for all ROIs, the
y-axis SNR scale is larger for pyruvate due
to a larger amount of signal from pyruvate
compared with other metabolites

measurements were between 5% and 7%, and the polarization level was not significantly different between msVFA and
CFA, as determined by a paired t-test (P = 0.15).
Qualitatively, we can appreciate that the increased SNR
in images collected using the msVFA acquisition allowed
us to better discern the signal in less perfused and/or metabolically active areas compared with the lower SNR images

acquired using the CFA method. This allowed us to better
distinguish low metabolism values from noise and to detect
small changes in metabolism. We were able to distinguish
signal in the fetal livers more often in images acquired using
msVFA compared with CFA. An example of this is displayed
in Figure 4, where we notice more signal in placentae and
fetal livers in the image acquired using the msVFA technique.

SMITH et al.
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FIGURE 4

Typical hyperpolarized
C metabolite images overlaid on axial
T1 of the same animal at 30 seconds after
injection. Four pairs of images are shown
here for each metabolite: magenta, pyruvate
(top left); yellow, lactate (top right); green,
alanine (bottom left); and cyan, bicarbonate
(bottom right). For each pair of images, the
image on the left was acquired using CFA
and the image on the right acquired using
msVFA. The image pairs have identical
window and level for each metabolite.
Placentae are indicated by blue arrows and
outline, and fetal livers are indicated by
red arrows and outline. A different slice is
shown for alanine and bicarbonate, to show
increased bicarbonate signal in the placenta
using msVFA
13

4 | D IS C U SSION A N D
CONC LU S IO N S
In this study, we demonstrated that a spectrally varying dynamic flip-angle scheme individually optimized for each
metabolite increases the SNR for all metabolites in timeresolved metabolic imaging. We have shown up to 250% increases in SNR in pyruvate, lactate, and bicarbonate images
of the placentae, and demonstrated similar SNR increases for
metabolites in the maternal liver. The lack of alanine signal
in the maternal liver may be related to the known decrease of
alanine aminotransferase enzyme activity in the liver that occurs during pregnancy, although this has only been reported
on in human studies.20,21 The increased incidence of signal
seen in fetal livers using msVFA compared with CFA leads
us to believe that msVFA may be useful for metabolic analysis of fetal organs, where otherwise the signal may not be
distinguishable from noise.
The msVFA approach combats the rapid decay of hyperpolarized signal while accounting for the variation in metabolite
concentrations and T1 rates in hyperpolarized [1-13C]pyruvate MRI. The delivery of flip angles optimized for different
metabolites in HP13C-MRI builds on studies that have shown
the advantage of VFA techniques to counteract the rapid hyperpolarized decay.8,10,12,13,22 In these previous studies, VFA
was optimized for one metabolite, usually either pyruvate or
lactate, leading to suboptimal flip angles for other metabolites.

Alternative approaches to optimize SNR for multiple metabolites have used spectrally selective RF pulses, which apply
a unique flip angle for each metabolite but only excite one
metabolite per RF pulse.10,11,13,14 These approaches to date
have only been used to optimize up to two metabolites, usually pyruvate and lactate, and are usually implemented for imaging 2D slices. In our application of fetoplacental imaging,
3D imaging has the advantage of ensuring we can image multiple placentae and fetuses, which would be difficult if limited
to a single 2D slice. The msVFA technique uses a spectrally
varying flip angle, which delivers unique flip angles for each
metabolite during every RF excitation. The msVFA method
does not limit the number of metabolites for which we may
use optimized flip angles, and scaling up msVFA for more
metabolites would be possible with a change in the RF excitation pulse shape. The current implementation of msVFA
does not use the exact VFA flip angles for each metabolite due
to limitations of the double Gaussian RF pulse. Delivering the
exact desired flip angles may be possible, as one could imagine using a more sophisticated RF pulse design; however,
more complex pulses may be associated with additional complications such as higher specific absorption rate and likely
longer pulses, which we want to avoid in hyperpolarized experiments. Although both methods of achieving multimetabolite VFA are valid, unique advantages and weaknesses exist
for either method. We consider our stepwise msVFA to be a
step toward a fully optimized VFA for 3D volumes.
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The msVFA technique may be generalized for any set of
metabolites in hyperpolarized imaging, assuming that a rough
estimate of the T1 and metabolic rate constant is known. This
would be valuable for hyperpolarized imaging of any metabolite, particularly if the end goal is quantitative analysis. The
in vivo T1 rates of these metabolites are difficult to measure
and not well characterized; however, the msVFA optimization is dependent on the ratio of TR/T1, and hyperpolarized
imaging sequences typically use TR << T1 due to the limited lifetime of hyperpolarized signal. Therefore, the msVFA
optimization calculation is relatively insensitive to errors of
in vivo T1 estimation. Similarly, flip-angle optimization calculations from Xing et al13 used the assumed metabolic rate
constant values in the estimation of the effective T1, which
is inversely related to the rate constant. These metabolic rate
constants are not well known in vivo, but as previously, we do
not expect errors in rate constant estimation to affect SNR, as
TR << T1eff in our sequence.
The metabolic rate constants measured in vivo are typically on the order of 10−2 or 10−3 s−1, and precision is important when quantifying such small values. We predict that
the increased SNR produced in images acquired with msVFA
will improve the precision of metabolic rate fitting, enhancing the ability to detect small changes in these values. A
future application of this work would be to quantify and compare metabolic rate constant values in diseased and healthy
placentae using the msVFA acquisition.
In this study we have a large degree of biological variation among our animals, including different maternal ages,
gestational ages, and number of fetoplacental units. We chose
to include a diverse population for in vivo experiments to
demonstrate that the advantages of using msVFA are applicable to different populations, meaning that the msVFA would
not bias the results when comparing two groups of animals.
For these 13C acquisitions, we were able to use the birdcage coil to limit the guinea pig volume we wished to image.
If we were to translate this technique to application in large
animal or human studies, the RF pulse would need to be redesigned to include spatial selectivity. This adaptation is an
important topic for future work.
In summary, we have demonstrated that msVFA results
in improved overall SNR for all metabolites in in vivo hyperpolarized [1-13C]pyruvate MRI. This was achieved using a
spectrally varying RF pulse that increases in amplitude over
the duration of the scanning protocol, preserving hyperpolarized 13C signal more effectively than a flip-angle scheme that
is constant over time. Although we have focused on reporting
the SNR for ROIs in the placentae, maternal liver, and maternal kidneys, this technique could improve SNR for any organ
where metabolism is occurring. Additionally, this technique
may be generalized for metabolic imaging of any hyperpolarized substrate. The msVFA technique improves hyperpolarized 13C images to allow better quantitative analysis of

SMITH et al.

metabolic rates, and this is an important step in translation of
HP13C-MRI to clinical applications.
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